Combination treatment Anti‐DKK1 + ASCs showed a significant reduction in residual defect span, while either cell therapy or anti‐DKK1 alone showed a nonsignificant trend toward reduction in defect span (Figure 2B ).
← all excerpts
Systemic DKK1 neutralization enhances human adipose-derived stem cell mediated bone repair.
1
—
—